Global Progesterone Market by Type (Natural Progesterone, Synthetic Progesterone), Mode of Delivery (Injectable, Oral, Suspended Form), Application - Forecast 2024-2030- Product Image

Sale

Global Progesterone Market by Type (Natural Progesterone, Synthetic Progesterone), Mode of Delivery (Injectable, Oral, Suspended Form), Application - Forecast 2024-2030

Report
183 Pages
March 2024
Region: Global
360iResearch™
ID: 5925110

UP TO €846EUR$875USD£722GBP OFF until Dec 31^st 2024

The Progesterone Market size was estimated at USD 1.30 billion in 2023, USD 1.47 billion in 2024, and is expected to grow at a CAGR of 13.39% to reach USD 3.14 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Progesterone Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Progesterone Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Progesterone Market, highlighting leading vendors and their innovative profiles. These include Alkem Laboratories Ltd., Aquatic Remedies Pvt. Ltd, Bionpharma, Inc., Blubell Pharma Group Company, Cadila Pharmaceuticals, Caesar & Loretz Gmbh, Cipla Limited, Estrellas Life Sciences Private Limited, Fagron Industry, Glenmark Pharmaceuticals, Intas Pharmaceuticals Ltd., Lupin Limited, Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Shandong Octagon Chemicals Limited, Shanghai Yijing Industrial Co., Ltd., Sigmak Life Sciences, Sofgen Pharmaceuticals Llc, Teva Pharmaceuticals Industries Ltd., Virtus Pharmaceuticals Llc, and Wuhan Honor Bio-Pharm Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Progesterone Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Natural Progesterone
- Synthetic Progesterone
Mode of Delivery
- Injectable
- Oral
- Suspended Form
Application
- Contraception
- Dysfunctional Uterine Bleeding
- Endometrial Cancer
- Hyperplastic Precursor Lesions
- Regulation of the Menstrual Cycle

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Progesterone Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Progesterone Market?
What are the technology trends and regulatory frameworks in the Progesterone Market?
What is the market share of the leading vendors in the Progesterone Market?
Which modes and strategic moves are suitable for entering the Progesterone Market?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Progesterone Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of amenorrhea, breast cancer, and AIDS
5.1.1.2. Growing female infertility rates all over the globe
5.1.1.3. Increasing demand owing to different gynecological treatment
5.1.2. Restraints
5.1.2.1. Concern associated with side effects of progesterone and progestin
5.1.3. Opportunities
5.1.3.1. Technological advancements in the medical field
5.1.3.2. Ongoing research and development activities
5.1.4. Challenges
5.1.4.1. Lack of awareness about hormone therapy
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Progesterone Market, by Type
6.1. Introduction
6.2. Natural Progesterone
6.3. Synthetic Progesterone

7. Progesterone Market, by Mode of Delivery
7.1. Introduction
7.2. Injectable
7.3. Oral
7.4. Suspended Form

8. Progesterone Market, by Application
8.1. Introduction
8.2. Contraception
8.3. Dysfunctional Uterine Bleeding
8.4. Endometrial Cancer
8.5. Hyperplastic Precursor Lesions
8.6. Regulation of the Menstrual Cycle

9. Americas Progesterone Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Progesterone Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Progesterone Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Alkem Laboratories Ltd.
13.1.2. Aquatic Remedies Pvt. Ltd
13.1.3. Bionpharma, Inc.
13.1.4. Blubell Pharma Group Company
13.1.5. Cadila Pharmaceuticals
13.1.6. Caesar & Loretz Gmbh
13.1.7. Cipla Limited
13.1.8. Estrellas Life Sciences Private Limited
13.1.9. Fagron Industry
13.1.10. Glenmark Pharmaceuticals
13.1.11. Intas Pharmaceuticals Ltd.
13.1.12. Lupin Limited
13.1.13. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
13.1.14. Shandong Octagon Chemicals Limited
13.1.15. Shanghai Yijing Industrial Co., Ltd.
13.1.16. Sigmak Life Sciences
13.1.17. Sofgen Pharmaceuticals Llc
13.1.18. Teva Pharmaceuticals Industries Ltd.
13.1.19. Virtus Pharmaceuticals Llc
13.1.20. Wuhan Honor Bio-Pharm Co., Ltd.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. PROGESTERONE MARKET RESEARCH PROCESS
FIGURE 2. PROGESTERONE MARKET SIZE, 2023 VS 2030
FIGURE 3. PROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PROGESTERONE MARKET DYNAMICS
FIGURE 7. PROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. PROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
FIGURE 10. PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. PROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023

List of Tables
TABLE 1. PROGESTERONE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PROGESTERONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. PROGESTERONE MARKET SIZE, BY NATURAL PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PROGESTERONE MARKET SIZE, BY SYNTHETIC PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 9. PROGESTERONE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PROGESTERONE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PROGESTERONE MARKET SIZE, BY SUSPENDED FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. PROGESTERONE MARKET SIZE, BY CONTRACEPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PROGESTERONE MARKET SIZE, BY DYSFUNCTIONAL UTERINE BLEEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PROGESTERONE MARKET SIZE, BY ENDOMETRIAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PROGESTERONE MARKET SIZE, BY HYPERPLASTIC PRECURSOR LESIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PROGESTERONE MARKET SIZE, BY REGULATION OF THE MENSTRUAL CYCLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS PROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. CANADA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 30. CANADA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. MEXICO PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 33. MEXICO PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES PROGESTERONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. CHINA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 47. CHINA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. INDIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 50. INDIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. JAPAN PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 56. JAPAN PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. THAILAND PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 74. THAILAND PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. EGYPT PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 87. EGYPT PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. FINLAND PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 90. FINLAND PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. FRANCE PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 93. FRANCE PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. GERMANY PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 96. GERMANY PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. ITALY PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 102. ITALY PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. NORWAY PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 111. NORWAY PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. POLAND PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 114. POLAND PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. QATAR PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 117. QATAR PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. SPAIN PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 129. SPAIN PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. TURKEY PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 138. TURKEY PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. PROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 146. PROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. PROGESTERONE MARKET LICENSE & PRICING

Companies Mentioned

Alkem Laboratories Ltd.
Aquatic Remedies Pvt. Ltd
Bionpharma, Inc.
Blubell Pharma Group Company
Cadila Pharmaceuticals
Caesar & Loretz Gmbh
Cipla Limited
Estrellas Life Sciences Private Limited
Fagron Industry
Glenmark Pharmaceuticals
Intas Pharmaceuticals Ltd.
Lupin Limited
Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
Shandong Octagon Chemicals Limited
Shanghai Yijing Industrial Co., Ltd.
Sigmak Life Sciences
Sofgen Pharmaceuticals Llc
Teva Pharmaceuticals Industries Ltd.
Virtus Pharmaceuticals Llc
Wuhan Honor Bio-Pharm Co., Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	183
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.47 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.14 Billion
Compound Annual Growth Rate	13.3%
Regions Covered	Global
No. of Companies Mentioned	20

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,784GBP €3625EUR$3,749USD£3,093GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,526GBP €4592EUR$4,749USD£3,918GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5003EUR$5,174USD£4,269GBP €5559EUR$5,749USD£4,743GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5873EUR$6,074USD£5,011GBP €6526EUR$6,749USD£5,568GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,496GBP €8459EUR$8,749USD£7,218GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Progesterone Market Analysis & Forecast to 2024-2034: Market By Product; By Mode of Delivery; By Application; and By Region

Estrogen and Progesterone Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Hormone Replacement Therapy Market Size, Share & Trend Analysis By Product (Estrogen & Progesterone Replacement Therapy), By Route of Administration, By Disease Type, By Region, And Segment Forecasts, 2023 - 2030

Global Contraceptive Pills Market by Product (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Route of Administration, Distribution - Forecast 2024-2030

Global Oral Contraceptive Pills Market by Type (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Category, Distribution - Forecast 2024-2030

About the Progesterone Market